These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24246418)

  • 1. Polygenic risk for Alzheimer's disease is not associated with cognitive ability or cognitive aging in non-demented older people.
    Harris SE; Davies G; Luciano M; Payton A; Fox HC; Haggarty P; Ollier W; Horan M; Porteous DJ; Starr JM; Whalley LJ; Pendleton N; Deary IJ
    J Alzheimers Dis; 2014; 39(3):565-74. PubMed ID: 24246418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Stratification to Identify Risk Groups for Alzheimer's Disease.
    Marioni RE; Campbell A; Hagenaars SP; Nagy R; Amador C; Hayward C; Porteous DJ; Visscher PM; Deary IJ
    J Alzheimers Dis; 2017; 57(1):275-283. PubMed ID: 28222519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of ECE1 variants in cognitive ability in old age and Alzheimer's disease risk.
    Hamilton G; Harris SE; Davies G; Liewald DC; Tenesa A; Payton A; Horan MA; Ollier WE; Pendleton N; ; Starr JM; Porteous D; Deary IJ
    Am J Med Genet B Neuropsychiatr Genet; 2012 Sep; 159B(6):696-709. PubMed ID: 22693153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genome-wide association study implicates the APOE locus in nonpathological cognitive ageing.
    Davies G; Harris SE; Reynolds CA; Payton A; Knight HM; Liewald DC; Lopez LM; Luciano M; Gow AJ; Corley J; Henderson R; Murray C; Pattie A; Fox HC; Redmond P; Lutz MW; Chiba-Falek O; Linnertz C; Saith S; Haggarty P; McNeill G; Ke X; Ollier W; Horan M; Roses AD; Ponting CP; Porteous DJ; Tenesa A; Pickles A; Starr JM; Whalley LJ; Pedersen NL; Pendleton N; Visscher PM; Deary IJ
    Mol Psychiatry; 2014 Jan; 19(1):76-87. PubMed ID: 23207651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive change and the APOE epsilon 4 allele.
    Deary IJ; Whiteman MC; Pattie A; Starr JM; Hayward C; Wright AF; Carothers A; Whalley LJ
    Nature; 2002 Aug; 418(6901):932. PubMed ID: 12198535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease genes and cognition in the nondemented general population.
    Verhaaren BF; Vernooij MW; Koudstaal PJ; Uitterlinden AG; van Duijn CM; Hofman A; Breteler MM; Ikram MA
    Biol Psychiatry; 2013 Mar; 73(5):429-34. PubMed ID: 22592056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential roles of genetic factors in predicting ageing-related cognitive change and Alzheimer's disease.
    Pan G; King A; Wu F; Simpson-Yap S; Woodhouse A; Phipps A; Vickers JC
    Ageing Res Rev; 2021 Sep; 70():101402. PubMed ID: 34242808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent role of Alzheimer's disease genetics and C-reactive protein on cognitive ability in aging.
    Supiyev A; Karlsson R; Wang Y; Koch E; Hägg S; Kauppi K
    Neurobiol Aging; 2023 Jun; 126():103-112. PubMed ID: 36965205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic contributions to variation in general cognitive function: a meta-analysis of genome-wide association studies in the CHARGE consortium (N=53949).
    Davies G; Armstrong N; Bis JC; Bressler J; Chouraki V; Giddaluru S; Hofer E; Ibrahim-Verbaas CA; Kirin M; Lahti J; van der Lee SJ; Le Hellard S; Liu T; Marioni RE; Oldmeadow C; Postmus I; Smith AV; Smith JA; Thalamuthu A; Thomson R; Vitart V; Wang J; Yu L; Zgaga L; Zhao W; Boxall R; Harris SE; Hill WD; Liewald DC; Luciano M; Adams H; Ames D; Amin N; Amouyel P; Assareh AA; Au R; Becker JT; Beiser A; Berr C; Bertram L; Boerwinkle E; Buckley BM; Campbell H; Corley J; De Jager PL; Dufouil C; Eriksson JG; Espeseth T; Faul JD; Ford I; ; Gottesman RF; Griswold ME; Gudnason V; Harris TB; Heiss G; Hofman A; Holliday EG; Huffman J; Kardia SL; Kochan N; Knopman DS; Kwok JB; Lambert JC; Lee T; Li G; Li SC; Loitfelder M; Lopez OL; Lundervold AJ; Lundqvist A; Mather KA; Mirza SS; Nyberg L; Oostra BA; Palotie A; Papenberg G; Pattie A; Petrovic K; Polasek O; Psaty BM; Redmond P; Reppermund S; Rotter JI; Schmidt H; Schuur M; Schofield PW; Scott RJ; Steen VM; Stott DJ; van Swieten JC; Taylor KD; Trollor J; Trompet S; Uitterlinden AG; Weinstein G; Widen E; Windham BG; Jukema JW; Wright AF; Wright MJ; Yang Q; Amieva H; Attia JR; Bennett DA; Brodaty H; de Craen AJ; Hayward C; Ikram MA; Lindenberger U; Nilsson LG; Porteous DJ; Räikkönen K; Reinvang I; Rudan I; Sachdev PS; Schmidt R; Schofield PR; Srikanth V; Starr JM; Turner ST; Weir DR; Wilson JF; van Duijn C; Launer L; Fitzpatrick AL; Seshadri S; Mosley TH; Deary IJ
    Mol Psychiatry; 2015 Feb; 20(2):183-92. PubMed ID: 25644384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the CD2AP locus with cognitive functioning among middle-aged individuals with a family history of Alzheimer's disease.
    Manzali SB; Ravona-Springer R; Alkelai A; Yu E; Gan-Or Z; Ganmore I; Heymann A; Beeri MS; Greenbaum L
    Neurobiol Aging; 2021 May; 101():50-56. PubMed ID: 33578194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive Decline in Alzheimer's Disease: Limited Clinical Utility for GWAS or Polygenic Risk Scores in a Clinical Trial Setting.
    Euesden J; Gowrisankar S; Qu AX; Jean PS; Hughes AR; Pulford DJ
    Genes (Basel); 2020 May; 11(5):. PubMed ID: 32370229
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.
    Desikan RS; Fan CC; Wang Y; Schork AJ; Cabral HJ; Cupples LA; Thompson WK; Besser L; Kukull WA; Holland D; Chen CH; Brewer JB; Karow DS; Kauppi K; Witoelar A; Karch CM; Bonham LW; Yokoyama JS; Rosen HJ; Miller BL; Dillon WP; Wilson DM; Hess CP; Pericak-Vance M; Haines JL; Farrer LA; Mayeux R; Hardy J; Goate AM; Hyman BT; Schellenberg GD; McEvoy LK; Andreassen OA; Dale AM
    PLoS Med; 2017 Mar; 14(3):e1002258. PubMed ID: 28323831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1 + PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEɛ4 Carriers.
    Sapkota S; Dixon RA
    J Alzheimers Dis; 2018; 62(2):887-900. PubMed ID: 29480189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
    Bunce D; Fratiglioni L; Small BJ; Winblad B; Bäckman L
    Neurology; 2004 Sep; 63(5):816-21. PubMed ID: 15365129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuances in Alzheimer's Genetic Risk Reveal Differential Predictions of Non-demented Memory Aging Trajectories: Selective Patterns by APOE Genotype and Sex.
    McFall GP; Bäckman L; Dixon RA
    Curr Alzheimer Res; 2019; 16(4):302-315. PubMed ID: 30873923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic overlap between vascular pathologies and Alzheimer's dementia and potential causal mechanisms.
    Lin YF; Smith AV; Aspelund T; Betensky RA; Smoller JW; Gudnason V; Launer LJ; Blacker D
    Alzheimers Dement; 2019 Jan; 15(1):65-75. PubMed ID: 30240575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-dependent effect of APOE and polygenic component on Alzheimer's disease.
    Bellou E; Baker E; Leonenko G; Bracher-Smith M; Daunt P; Menzies G; Williams J; Escott-Price V;
    Neurobiol Aging; 2020 Sep; 93():69-77. PubMed ID: 32464432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.
    Lacour A; Espinosa A; Louwersheimer E; Heilmann S; Hernández I; Wolfsgruber S; Fernández V; Wagner H; Rosende-Roca M; Mauleón A; Moreno-Grau S; Vargas L; Pijnenburg YA; Koene T; Rodríguez-Gómez O; Ortega G; Ruiz S; Holstege H; Sotolongo-Grau O; Kornhuber J; Peters O; Frölich L; Hüll M; Rüther E; Wiltfang J; Scherer M; Riedel-Heller S; Alegret M; Nöthen MM; Scheltens P; Wagner M; Tárraga L; Jessen F; Boada M; Maier W; van der Flier WM; Becker T; Ramirez A; Ruiz A
    Mol Psychiatry; 2017 Jan; 22(1):153-160. PubMed ID: 26976043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparative Study of Pathological Outcomes in The University of Manchester Longitudinal Study of Cognition in Normal Healthy Old Age and Brains for Dementia Research Cohorts.
    Robinson AC; Chew-Graham S; Davidson YS; Horan MA; Roncaroli F; Minshull J; du Plessis D; Pal P; Payton A; Pendleton N; Mann DMA
    J Alzheimers Dis; 2020; 73(2):619-632. PubMed ID: 31796669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.